Indian Journal of Clinical and Experimental Ophthalmology

Print ISSN: 2395-1443

Online ISSN: 2395-1451

CODEN : IJCEKF

Indian Journal of Clinical and Experimental Ophthalmology (IJCEO) is open access, a peer-reviewed medical journal, published quarterly, online, and in print, by the Innovative Education and Scientific Research Foundation (IESRF) since 2015. To fulfil our aim of rapid dissemination of knowledge, we publish articles ‘Ahead of Print’ on acceptance. In addition, the journal allows free access (Open Access) to its content, which is likely to attract more readers and citations of articles published in IJCEO. Manuscripts must be prepared in more...

Article type

Original Article


Article page

263-265


Authors Details

Abhishek Agarwal, Nikhil Dixti, Neeti Garg, Rohini Godara


View Article As

 


Downlaod Files

   






Article statistics

Viewed: 1185

PDF Downloaded: 458


Rate of microbiological contamination of multi-use vials of bevacizumab and risk of endopthalmitis


Original Article

Author Details : Abhishek Agarwal, Nikhil Dixti, Neeti Garg, Rohini Godara

Volume : 2, Issue : 3, Year : 2016

Article Page : 263-265


Suggest article by email

Get Permission

Abstract

Introduction: To determine the rate of microbiological contamination in multi-use vials of bevacizumab used for multiple intravitreal injections and to determine the rate of endophthalmitis in patients who received intravitreal injections from these vials.
Methods: Eighteen 100-mg (4 mL) vials of bevacizumab (Avastin; F. Hoffmann-La Roche Ltd. Switzerland) were used for 327 intravitreal injections in period of 18 months. These vials were stored in refrigerator at 2 – 8oC for 30 days. From each vial, two samples of 0.05ml of avastin was withdrawn with the help of 1ml syringe at 7 and 30 days after the opening the vial. These samples were send for bacterial and fungal staining and culture. 327 patients who received intravitreal injections were monitored for signs and symptoms of inflammation or endopthalmitis.
Results: No evidence of microbiological contamination was detected in 18 vials sent for microbiological staining and culture. 327 patients who received intravitreal injections from these vials did not showed any signs or symptoms of inflammation or endopthalmitis.
Conclusions: Using the muti-use vials of bevacizumab for intravitreal injections which are stored for up to 30 days in refrigerator at 2–8oC is safe.

Keywords: Bevacizumab, Endopthalmitis, Microbiological contamination, Multi-use vial


How to cite : Agarwal A, Dixti N, Garg N, Godara R, Rate of microbiological contamination of multi-use vials of bevacizumab and risk of endopthalmitis. Indian J Clin Exp Ophthalmol 2016;2(3):263-265

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.